Relationship between TRAIL and Left Ventricular Ejection Fraction in Patients with ST-Elevation Myocardial Infarction Treated with Primary Percutaneous Coronary Intervention

Table 1

Baseline characteristics of the study population including medical history, index event and angiography characteristics and medication at discharge (n = 101).

Baseline characteristics
Age, years (mean, SD)	59.36 ± 10.00
Male gender (n, %)	75 (74.3)
BMI (mean, SD)	28.00 ± 4.07
DM (n, %)	17 (16.8)
Hypertension (n, %)	53 (52.5)
Smoking status (n, %)	82 (81.2)
History of MI (n, %)	10 (9.9)
Index event and angiography characteristics
Time-to-PCI, minutes (median, 25th, 75th percentile)	180 (120, 370)
Killip class
Killip class I-II	100 (99.0)
Killip class III	1 (1.0)
CAD severity (mean, SD)	1.85 ± 0.79
Infarct related artery
LAD (n, %)	41 (40.6)
LCx (n, %)	16 (15.8)
RCA (n, %)	44 (43.6)
Type of stent
BMS (n, %)	16 (15.8)
DES (n, %)	32 (31.7)
Absorb (n, %)	49 (48.5)
TIMI flow 3 after PCI (n, %)	98 (97)
Complete revascularization (n, %)	60 (60.0)
Medication at discharge
Beta-blocker (n, %)	92 (91.1)
ACE inhibitor (n, %)	90 (89.1)
Aspirin (n, %)	96 (95.1)
Statin (n, %)	99 (98.0)
Clopidogrel (n, %)	18 (17.8)
Prasugrel (n, %)	48 (47.5)
Ticagrelor (n, %)	35 (34.7)

BMI – body mass index, DM – the presence of diabetes mellitus, smoking status – smoking before admission, MI – myocardial infarction, time-to-pPCI – time from the onset of symptoms to primary percutaneous coronary intervention, LAD – left anterior descending artery, LCx – left circumflex artery, RCA – right coronary artery, BMS – bare metal stent, DES – drug eluting stent, Absorb – bioresorbable stent, TIMI flow – “thrombolysis in myocardial infarction” grade flow, complete revascularization – the absence of any stenosis of 60% or more in at least one coronary artery at discharge.